Reeteka Sud, Ph.D.
Affiliations: | 2005 | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Neuroscience BiologyGoogle:
"Reeteka Sud"Mean distance: 53433
Parents
Sign in to add mentorTracey A. Ignatowski | grad student | 2005 | SUNY Buffalo | |
(Brain -derived tumor necrosis factor-alpha (TNF) mediates the antinociceptive effect of amitriptyline and modulates brain -body interactions during neuropathic pain.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sud R, Spengler RN, Nader ND, et al. (2008) Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory. European Journal of Pharmacology. 588: 217-31 |
Spengler RN, Sud R, Knight PR, et al. (2007) Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release. Neuropharmacology. 52: 576-89 |
Sud R, Ignatowski TA, Lo CP, et al. (2007) Uncovering molecular elements of brain-body communication during development and treatment of neuropathic pain. Brain, Behavior, and Immunity. 21: 112-24 |
Reynolds JL, Ignatowski TA, Sud R, et al. (2005) An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience. 133: 519-31 |
Ignatowski TA, Sud R, Reynolds JL, et al. (2005) The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-alpha (TNF). Neuropharmacology. 48: 448-60 |
Reynolds JL, Ignatowski TA, Sud R, et al. (2004) Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant. The Journal of Pharmacology and Experimental Therapeutics. 310: 1216-25 |